Home › Funds › 13D Management LLC › CRL

13D Management LLC position in CRL

CHARLES RIV LABS INTL INC · Health Care

13D Management LLC reported holding 25,800 shares of CRL (CHARLES RIV LABS INTL INC) in its Q2 2026 13F filing — a position valued at US$5.9M, representing 8.20% of its reported portfolio and ranking #6 among its reported holdings. 13D Management LLC has disclosed CRL holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)25.80K sh
Reported value held$5.85M
Portfolio Weight8.20%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How 13D Management LLC's CRL position evolved

13D Management LLC first disclosed a stake in CRL in Q2 2025 at 28,000 shares (US$4.2M). The position peaked in Q2 2026 at 25,800 shares, worth US$5.9M. Across 5 filings, 13D Management LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 25,800 shares valued at US$5.9M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 28.00K $4.25M New
Q3 2025 28.00K $4.38M Hold
Q4 2025 28.00K $5.59M Hold
Q1 2026 25.80K $4.45M Reduce
Q2 2026 25.80K $5.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRL and 13F data

CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 30 other funds we track also report a position in CRL — the largest reported positions include Allspring Global Investments Holdings, LLC (US$436.5M), ARIEL INVESTMENTS, LLC (US$341.6M), EARNEST PARTNERS LLC (US$254.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRL

All CRL fund holders →

FAQ

How long has 13D Management LLC held CRL?

13D Management LLC has disclosed CRL holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is 13D Management LLC's current position in CRL?

As of Q2 2026, 13D Management LLC holds 25.80K shares of CRL (CHARLES RIV LABS INTL INC), valued at $5.85M, representing 8.20% of its reported portfolio and ranking #6.

Has 13D Management LLC been buying or selling CRL?

In the latest 13F filing (Q2 2026), 13D Management LLC held unchanged its position in CRL. The position peaked in Q2 2026 at 25.80K shares.

Which other funds hold CRL?

Other major institutional holders of CRL include Allspring Global Investments Holdings, LLC, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.